Baxter International Inc. (NYSE:BAX) Declares $0.01 Quarterly Dividend

Baxter International Inc. (NYSE:BAX) announced a quarterly dividend on Wednesday, April 29th. Investors of record on Friday, May 29th will be paid a dividend of 0.01 per share by the medical instruments supplier on Wednesday, July 1st. This represents a c) annualized dividend and a yield of 0.2%. The ex-dividend date is Friday, May 29th.

Baxter International has decreased its dividend payment by an average of 0.1%per year over the last three years. Baxter International has a payout ratio of 1.5% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Baxter International to earn $2.03 per share next year, which means the company should continue to be able to cover its $0.04 annual dividend with an expected future payout ratio of 2.0%.

Baxter International Trading Down 0.5%

BAX stock traded down $0.08 during trading on Friday, hitting $17.50. 5,061,300 shares of the company traded hands, compared to its average volume of 9,474,535. The firm has a market capitalization of $9.03 billion, a PE ratio of -9.45, a P/E/G ratio of 1.20 and a beta of 0.62. Baxter International has a 1 year low of $15.73 and a 1 year high of $32.68. The company has a 50-day moving average of $17.92 and a 200-day moving average of $19.18. The company has a debt-to-equity ratio of 1.55, a quick ratio of 1.56 and a current ratio of 2.31.

Baxter International (NYSE:BAX) last issued its earnings results on Thursday, April 30th. The medical instruments supplier reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.31 by $0.05. The company had revenue of $2.70 billion during the quarter, compared to analysts’ expectations of $2.62 billion. Baxter International had a positive return on equity of 16.95% and a negative net margin of 8.51%.Baxter International’s quarterly revenue was up 2.9% compared to the same quarter last year. During the same period in the prior year, the business posted $0.62 EPS. Analysts predict that Baxter International will post 1.91 earnings per share for the current fiscal year.

Key Baxter International News

Here are the key news stories impacting Baxter International this week:

• Positive Sentiment: Q1 revenue and EPS topped expectations — Baxter reported $2.70B in revenue and $0.36 EPS, above consensus, driven by robust medical products & therapies and overseas sales. This beat and commentary on stabilizing the business support upside potential. Baxter beats quarterly expectations on strong demand for medical devices
• Positive Sentiment: Management reiterated 2026 growth views and emphasized execution improvements and cost actions to stabilize margins — messaging that can reassure investors about the turnaround plan. Baxter Reports First-Quarter 2026 Results
• Neutral Sentiment: Detailed investor materials and the earnings-call transcript are available (slides and call highlight specific drivers and timing for margin recovery), useful for analysts and investors digging into segment trends and timing. Baxter International Inc. 2026 Q1 – Results – Earnings Call Presentation
• Negative Sentiment: Margins contracted and the company posted a quarter with lower EPS year-over-year (Q1 EPS down vs. prior year), and net-margin metrics remain negative — these profit pressures are a clear risk to valuation and investor sentiment. BAX Stock Gains on Q1 Earnings & Sales Beat, Margins Contract
• Negative Sentiment: At least one research house trimmed its price target despite keeping a positive rating, signaling cautious sentiment among some analysts and creating downward pressure on the stock. Evercore Cuts Baxter (BAX) Price Target, Keeps Outperform Rating

Baxter International Company Profile

Baxter International Inc is a global healthcare company that develops, manufactures and markets a broad portfolio of medical products, pharmaceutical therapies and biotechnology-based solutions. The company’s primary business activities are organized around renal care, medication delivery, acute therapies, pharmacy automation, surgical care and biotechnology. Baxter’s offerings are designed to support patient care in hospitals, dialysis centers, nursing homes and other healthcare facilities worldwide.

In the renal care segment, Baxter provides hemodialysis and peritoneal dialysis systems, water treatment equipment and related disposables, including dialyzers, bloodlines and catheters.